Lucy O. Day

Ms. Day is AN2’s Chief Financial Officer, responsible for finance, human capital, and administrative functions. Previously, Ms. Day led a number of finance and administrative functions at Anacor Pharmaceuticals over a 14-year period, initially as CFO, then focusing on legal matters and human resources. While at Anacor, Ms. Day built and led the Finance and Accounting functions, and was instrumental in preparing for and completing private and public financings, drug product launches, and numerous research and development collaborations. In the earlier years, Ms. Day reviewed and oversaw legal matters of the Company, and led the due diligence process for all financings, including the IPO and acquisition by Pfizer. Ms. Day also led the HR function during commercialization of Eucrisa®, acquisition by Pfizer, and subsequent transition into Pfizer’s culture. Prior to Anacor, Ms. Day served in a similar capacity as CFO at Centaur Pharmaceuticals, where she helped grow the startup from early research to late-stage clinical development. Ms. Day started her career at Ernst & Young and has previous financial experience at Sohio Petroleum and as a VP at Bank of America. She is a University of California, Berkeley graduate and is a CPA (non-active) in California.